Clinical trials
Phase 3 Coronary Artery Disease trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| AstraZeneca | 4 |
| Boston Scientific Corporation | 4 |
| Novartis Pharmaceuticals | 3 |
| Abbott Medical Devices | 2 |
| Bayer | 2 |
| Air Liquide Santé International | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alvimedica | 1 |
| CSL Behring | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 36 |
| Myocardial Infarction | 6 |
| Cardiovascular Diseases | 4 |
| Myocardial Ischemia | 4 |
| Stroke | 4 |
| Acute Coronary Syndrome | 3 |
| Coronary Stenosis | 3 |
| Heart Diseases | 3 |
| Peripheral Arterial Disease | 3 |
| Angina Pectoris | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.